Ni, W.* et al. Low and high air temperature and cardiovascular risk. Atherosclerosis 406:119238 (2025)
Trimaglio, G.* ; Mirtschink, P.* ; El-Armouche, A.* & Chavakis, T. Cardiac macrophages and their functions in homeostasis and injury. Atherosclerosis 409:120480 (2025)
Garcia, T.* et al. Relationship of proteins and subclinical cardiovascular traits in the population-based LIFE-Adult study. Atherosclerosis 398:118613 (2024)
Meng, Y.* et al. Endothelial epoxyeicosatrienoic acid release is intact in aldosterone excess. Atherosclerosis 398:118591 (2024)
Meng, Y.* et al. Corrigendum to "Endothelial epoxyeicosatrienoic acid release is intact in aldosterone excess" [Atherosclerosis 398 (2024) 118591]. Atherosclerosis 401:119071 (2024)
Kheirkhah, A.* et al. Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations. Atherosclerosis 386:117384 (2023)
Grüneis, R.* et al. The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A. Atherosclerosis 349, 151-159 (2022)
Schnitzer, F.* et al. Association between a polygenic and family risk score on the prevalence and incidence of myocardial infarction in the KORA-F3 study. Atherosclerosis 352, 10-17 (2022)
Simonetto, C. et al. Risk for cardiovascular events responds nonlinearly to carotid intima-media thickness in the KORA F4 study. Atherosclerosis 296, 32-39 (2020)
Then, C. et al. Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study. Atherosclerosis 297, 1-7 (2020)
Breuninger, T. et al. Associations between fecal bile acids, neutral sterols, and serum lipids in the KORA FF4 study. Atherosclerosis 288, 1-8 (2019)
Coassin, S.* et al. A comprehensive map of the variability in the lipoprotein (A) KIV 2 repeat region and follow-up of the KIV-2 ARG20TER mutation in 11,000 individuals. Atherosclerosis 287, E58-E58 (2019)
Saulnier-Blache, J.S.* et al. Ldlr-/- and ApoE-/- mice better mimic the human metabolite signature of increased carotid intima media thickness compared to other animal models of cardiovascular disease. Atherosclerosis 276, 140-147 (2018)
Sulkava, M.* et al. Formyl peptide receptors 1-3 and annexin 1 in atherosclerotic plaques  - tampere vascular study. Atherosclerosis 275, E104-E105 (2018)
Ladwig, K.-H. et al. Room for depressed and exhausted mood as a risk predictor for all-cause and cardiovascular mortality beyond the contribution of the classical somatic risk factors in men. Atherosclerosis 257, 224-231 (2017)
Braenne, I.* et al. Pleiotropic molecular targets of coxibs reveals novel genomic loci conferring coronary artery disease risk. Atherosclerosis 252, E252-E253 (2016)
Dalla Pozza, R.* et al. Beyond intima-media-thickness: Analysis of the carotid intima-media-roughness in a paediatric population. Atherosclerosis 251, 164-169 (2016)
Kollerits, B.* et al. Plasma concentrations of afamin are associated with the prevalence and incidence of type 2 diabetes mellitus. Atherosclerosis 252, E217-E218 (2016)
Pfeiffer, L. et al. Associations between lipoprotein subfractions and genome-wide DNA methylation in KORA F4. Atherosclerosis 252, E263-E263 (2016)
Schratter, G.* et al. Liposomes for microRNA delivery to human adipocytes. Atherosclerosis 252, E131-E131 (2016)
Then, C. et al. Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study. Atherosclerosis 252, 88-96 (2016)
Tomas, L.* et al. A lipid metabolite profile in atherosclerotic plaques associated with increased inflammation and cardiovascular. Atherosclerosis 252, E260-E260 (2016)
von Essen, M.* et al. Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. Atherosclerosis 255, 43-53 (2016)
Wildgruber, M.* et al. Increased intermediate CD14++CD16++ monocyte subset levels associate with restenosis after peripheral percutaneous transluminal angioplasty. Atherosclerosis 253, 128-134 (2016)
Jansen, H.* et al. Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. Atherosclerosis 241, 419-426 (2015)
Oksala, N.* et al. Kindlin 3 (FERMT3) is associated with unstable atherosclerotic plaques, anti-inflammatory type II macrophages and upregulation of beta-2 integrins in all major arterial beds. Atherosclerosis 242, 145-154 (2015)
Thiele, I. et al. Associations between calcium and vitamin D supplement use as well as their serum concentrations and subclinical cardiovascular disease phenotypes. Atherosclerosis 241, 743-751 (2015)
Dieplinger, H.* et al. Plasma concentrations of afamin are associated with the prevalence and developement of metabolic syndrome. Atherosclerosis 235, E70-E71 (2014)
Huang, H.* et al. Induction of inducible Nitric Oxide Synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration. Atherosclerosis 235, 213-222 (2014)
Lamina, C.* et al. Correlation between a positive family risk score and peripheral artery disease in one case-control and two population-based studies. Atherosclerosis 237, 243-250 (2014)
Dastani, Z.* et al. The shared allelic architecture of adiponectin levels and coronary artery disease. Atherosclerosis 229, 145-148 (2013)
Raitoharju, E.* et al. A comparison of the accuracy of Illumina HumanHT-12 v3 Expression BeadChip and TaqMan qRT-PCR gene expression results in patient samples from the Tampere Vascular Study. Atherosclerosis 226, 149-152 (2013)
Stöckl, D. et al. Reproductive factors and its association with peripheral arterial disease in women aged 52-81 years: The KORA F4 study. Atherosclerosis 228, 224-229 (2013)
Then, C. et al. Plasma MR-proANP levels are associated with carotid intima-media thickness in the general community: The KORA F4 study. Atherosclerosis 230, 235-241 (2013)
Lamina, C.* et al. Evaluation of gene-obesity interaction effects on cholesterol levels: A genetic predisposition score on HDL-cholesterol is modified by obesity. Atherosclerosis 225, 363-369 (2012)
Wassel, C.L.* et al. Genetic determinants of the ankle-brachial index: A meta-analysis of a cardiovascular candidate gene 50K SNP panel in the Candidate gene Association Resource (CARe) consortium. Atherosclerosis 222, 138-147 (2012)
Autenrieth, C.S. et al. Myeloperoxidase, but not oxidized LDL, is associated with leisure-time physical activity: Results from the MONICA/KORA Augsburg Studies 1984-1995. Atherosclerosis 219, 774-777 (2011)
Conde, L.* et al. Novel associations for coronary artery disease derived from genome wide association studies are not associated with increased carotid intima-media thickness, suggesting they do not act via early atherosclerosis or vessel remodeling. Atherosclerosis 219, 684-689 (2011)
Koch, W.* et al. The chromosome 9p21 region and myocardial infarction in a European population. Atherosclerosis 217, 220-226 (2011)
Lamina, C.* ; Coassin, S.* ; Illig, T. & Kronenberg, F.* Look beyond one's own nose: Combination of information from publicly available sources reveals an association of GATA4 polymorphisms with plasma triglycerides. Atherosclerosis 219, 698-703 (2011)
Möhlenkamp, S.* et al. Coronary artery calcium score improves cardiovascular risk prediction in persons without indication for statin therapy. Atherosclerosis 215, 229-236 (2011)
Raitoharju, E.* et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219, 211-217 (2011)
Raitoharju, E.* et al. Common variation in the ADAM8 gene affects serum sADAM8 concentrations and the risk of myocardial infarction in two independent cohorts. Atherosclerosis 218, 127-133 (2011)
Heid, I.M. et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: Results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 208, 412-420 (2010)
Karakas, M.* et al. Leptin, adiponectin, their ratio and risk of Coronary Heart Disease: Results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis 209, 220-225 (2010)
Linsel-Nitschke, P.* et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 208, 183-189 (2010)
Hersberger, M.* et al. No association of two functional polymorphisms in human ALOX15 with myocardial infarction. Atherosclerosis 205, 192-196 (2009)
Herder, C.* et al. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis 200, 380-388 (2008)
Kollerits, B.* et al. Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality. A population-based prospective cohort study with 30 years of follow-up. Atherosclerosis 198, 214-222 (2008)
Meisinger, C. ; Döring, A. ; Schneider, B. & Löwel, H. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189, 297-302 (2006)
Thorand, B. et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184, 216-224 (2006)
Döring, A. ; Fröhlich, M.* ; Löwel, H. & Koenig, W.* Third generation oral contraceptive use and cardiovascular risk factors. Atherosclerosis 172, 281-286 (2004)
Hense, H.W. ; Stender, M. ; Bors, W. & Keil, U. Lack of an Association Between Serum Vitamin E and Myocardinal Infarction in a Population with high Vitamin E Levels. Atherosclerosis 103, 21-28 (1993)
Berndt, J. ; Gaumert, R. & Still, J.S. Mode of action of the lipid-lowering agents, elofibrate and BM 15075, on cholesterol biosynthesis in rat liver. Atherosclerosis 30, 147-152 (1978)